UNIGE document Scientific Article
previous document  unige:55288  next document
add to browser collection
Title

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO)

Authors
Maibach, R
Martinelli, G
Fazio, N
Aapro, M S
Pagani, O
Morant, R
Borner, M M
show hidden authors show all authors [1 - 14]
Published in Annals of Oncology. 2000, vol. 11, no. 3, p. 301-6
Abstract A multi-centric trial was performed to explore the clinical activity, in terms of response and toxicity (primary objectives), duration of response and survival (secondary objectives), of docetaxel with cisplatin in advanced gastric cancer (AGC).
Keywords Adenocarcinoma/drug therapy/mortality/secondaryAntineoplastic Combined Chemotherapy Protocols/adverse effects/therapeutic useCisplatin/administration & dosage/adverse effectsHumansPaclitaxel/administration & dosage/adverse effects/analogs & derivativesStomach Neoplasms/drug therapy/mortality/pathologySurvival AnalysisTaxoids
Identifiers
PMID: 10811496
Full text
Structures
Research group Groupe Roth Arnaud (oncologie) (285)
Citation
(ISO format)
ROTH, Arnaud et al. Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). In: Annals of Oncology, 2000, vol. 11, n° 3, p. 301-6. https://archive-ouverte.unige.ch/unige:55288

152 hits

86 downloads

Update

Deposited on : 2015-04-09

Export document
Format :
Citation style :